Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Colazal (balsalazide disodium) Capsules, Salix NDA 20-610/S1 6/18/02 6/24/02 Colazal (balsalazide disodium) Capsules, Salix NDA 20-610 7/18/00 7/25/00 7/25/00 7/31/02 Colazal Indications: Treatment of mildly to moderately active Ulcerative Colitis. | Colazal (balsalazide disodium) Capsules, Salix Pharma, Package Change | Colazal (balsalazide disodium) Capsules, Salix Pharma, Labeling Revision | Colazal (balsalazide disodium) Capsules, Salix Pharma, Patient Population Altered | Colazal (balsalazide disodium) Capsules, Salix Pharma, Labeling Revision | Balsalazide Disodium Capsules, Mylan Pharma, Approval | Balsalazide Disodium Capsules, Apotex, Approval | Balsalazide Disodium Capsules, Roxane Labs, Approval | Colazal (balsalazide disodium) Capsules, Salix Pharmaceuticals, Inc., Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com